Cargando…
Randomised clinical trial: tegoprazan, a novel potassium‐competitive acid blocker, or lansoprazole in the treatment of gastric ulcer
BACKGROUND: Tegoprazan is a novel potassium‐competitive acid blocker for the treatment of acid‐related disorders. AIMS: To assess whether tegoprazan is non‐inferior to lansoprazole in terms of efficacy and safety in patients with gastric ulcers. METHODS: In this phase 3, double‐blind, active control...
Autores principales: | Cho, Yu Kyung, Choi, Myung‐Gyu, Choi, Suck Chei, Lee, Kee Myung, Kim, Tae Oh, Park, Soo‐Heon, Moon, Jeong Seop, Lim, Yun Jeong, Kang, Dae Hwan, Cheon, Gab Jin, Baik, Gwang Ho, Kim, Kyoung Oh, Cho, Kwang Bum, Jang, Jin Seok, Park, Jong‐Jae, Son, Byoung Kwan, Jung, Hye‐Kyung, Kim, Byung‐Wook, Kim, Sung Kuk, Lee, Soo Teik, Cha, Jae Myung, Kim, Ah Rong, Kim, Eun Ji, Park, Hyun Wook, Song, Geun Seog |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496685/ https://www.ncbi.nlm.nih.gov/pubmed/32701188 http://dx.doi.org/10.1111/apt.15865 |
Ejemplares similares
-
Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oesophagitis
por: Cho, Yu Kyung, et al.
Publicado: (2022) -
Randomised phase 3 trial: tegoprazan, a novel potassium‐competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis
por: Lee, Kwang Jae, et al.
Publicado: (2019) -
Randomised clinical trial: comparison of tegoprazan and placebo in non‐erosive reflux disease
por: Kim, Seung Han, et al.
Publicado: (2021) -
Comparative Efficacy of 14-Day Tegoprazan-Based Triple vs. 10-Day Tegoprazan-Based Concomitant Therapy for Helicobacter pylori Eradication
por: Park, Chan Hyuk, et al.
Publicado: (2022) -
The effects of extracorporeal shock wave therapy vs hand massage on serum lipids in overweight and obese women
por: Lee, Kyung.Jin, et al.
Publicado: (2021)